Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Aurora Cannabis Sets Up US$100 Million ATM Equity Program With TD Securities

Tipranks - Thu Feb 5, 4:18PM CST

Claim 50% Off TipRanks Premium

Aurora Cannabis ( (TSE:ACB) ) has shared an announcement.

On February 4, 2026, Aurora Cannabis Inc. entered into a sales agreement with TD Securities (USA) LLC that allows the company, from time to time and at its discretion, to issue and sell up to US$100 million of its common shares through TD Securities acting as agent and/or principal. The at-the-market style facility is backed by previously filed Canadian and U.S. shelf prospectuses covering up to US$250 million of various securities, reinforcing Aurora’s ability to tap equity markets on an as-needed basis. This arrangement enhances the company’s financial flexibility but also signals potential future share dilution for existing shareholders as Aurora uses the program to raise capital in support of its operational and strategic objectives.

The most recent analyst rating on (TSE:ACB) stock is a Hold with a C$5.50 price target. To see the full list of analyst forecasts on Aurora Cannabis stock, see the TSE:ACB Stock Forecast page.

Spark’s Take on TSE:ACB Stock

According to Spark, TipRanks’ AI Analyst, TSE:ACB is a Neutral.

Overall score reflects weak core financial performance (ongoing profitability and cash-flow challenges) and bearish technicals (below key moving averages with negative MACD). These are partially offset by a more positive earnings-call outlook centered on higher-margin global medical growth and EBITDA guidance, while valuation signals are limited due to negative earnings and no dividend.

To see Spark’s full report on TSE:ACB stock, click here.

More about Aurora Cannabis

Aurora Cannabis Inc. is a Canadian cannabis producer based in Edmonton, Alberta, focused on cultivating, processing and selling cannabis and cannabis-derived products for medical and adult-use markets in Canada and internationally. The company accesses capital markets in both Canada and the United States and utilizes shelf prospectuses and cross-border registration to support ongoing financing and growth initiatives.

Average Trading Volume: 556,396

Technical Sentiment Signal: Sell

Current Market Cap: C$305.1M

See more insights into ACB stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.